Bishoy Morris Faltas, Chief Research Officer at Weill Cornell Medicine, shared a post on LinkedIn:
“Excited to share our new paper in collaboration with Fei Wang to develop a cutting-edge AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in the S1314 randomized clinical trial.
Full X-plainer here.”
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post by Bishoy Morris Faltas, adding:
“Innovative approach to utilize AI. Congratulations to Dr. Bishoy Morris Faltas and team of Weill Cornell Medicine.”
Authors: Zilong Bai et al.
